PTI - Proteostasis Therapeutics, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Pharmaceutical Preparations - PTI (1445283)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
P - Purchase
S - Sale
A - Grant
D - Sale to Iss
G - Gift
F - Tax
M - Option Ex
X - Option Ex
C - Cnv Deriv
W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title   Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10% Own
  Other
Group by
Sort by
Max Results
Page
clear
Real-time CSV, Options, Alerts
7 results - Yahoo - Finviz - Stockcharts - Tradingview - Stocktwits - SEC
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Insider Title

Trade Type 

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

M
2019-11-26
PTINew Enterprise Associates 12, Limited Partnership10%S - Sale$2.51-1,283,9194,270,691-23%-$3,228,873
D
2019-02-04
PTIMunoz BenitoChief Scientific OfficerS - Sale+OE$2.99-9,51415,439-38%-$28,454
D
2019-02-04
PTILee Po ShunSee RemarksS - Sale+OE$2.99-9,93118,427-35%-$29,700
D
2019-02-04
PTIGilmartin Geoffrey S.Chief Development OfficerS - Sale+OE$2.99-9,18914,911-38%-$27,480
D
2019-02-04
PTIChhabra MeenuPres, CEOS - Sale+OE$2.99-16,47880,615-17%-$49,305
M
2019-01-28
PTILee Po ShunSee RemarksS - Sale$3.00-2,3122,312-50%-$6,936
2018-10-26
PTIBerger Franklin MDirP - Purchase$6.75+40,000306,162+15%+$270,000
AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top